市場調査レポート

商品コード

1272069

マイクロ流体デバイスの世界市場の予測（～2027年）

Microfluidics Device Market Forecast till 2027

出版日: 2023年05月03日
発行: Market Research Future
ページ情報: 英文 110 Pages
納期: 即納可能

価格

PDF & Excel (Single User License)

USD 4,950 713,097円

レポートPDF、Excelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。

PDF & Excel (Multi User License)

USD 5,950 857,157円

レポートPDF、Excelを同一企業内の最大15名がご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。

PDF & Excel (Enterprise License)

USD 7,250 1,044,435円

レポートPDF、Excelを同一企業内のすべての方がご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDF、Excelの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のマイクロ流体デバイス市場は、主にチップや検査製品を小型化するためのマイクロ流体技術に対する需要の増加と、ゲノミクスやプロテオミクスの需要の向上によって成長が促進される見込みです。

当レポートでは、世界のマイクロ流体デバイス市場について調査分析し、市場力学、地域とセグメントの分析、企業プロファイルなどを提供しています。

LIST OF TABLES

TABLE 1 MICROFLUIDICS DEVICES MARKET SYNOPSIS, 2017-2027
TABLE 2 MICROFLUIDICS DEVICES MARKET ESTIMATES AND FORECAST, 2017-2027 (USD MILLION)
TABLE 3 GLOBAL MICROFLUIDICS DEVICES MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 4 GLOBAL MICROFLUIDICS DEVICES MARKET, BY INDUSTRY, 2017-2027 (USD MILLION)
TABLE 5 GLOBAL MICROFLUIDICS DEVICES MARKET, BY MATERIAL, 2017-2027 (USD MILLION)
TABLE 6 GLOBAL MICROFLUIDICS DEVICES MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 7 NORTH AMERICA: MICROFLUIDICS DEVICES MARKET, BY INDUSTRY, 2017-2027 (USD MILLION)
TABLE 8 NORTH AMERICA: MICROFLUIDICS DEVICES MARKET, BY MATERIAL, 2017-2027 (USD MILLION)
TABLE 9 NORTH AMERICA: MICROFLUIDICS DEVICES MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 10 US: MICROFLUIDICS DEVICES MARKET, BY INDUSTRY, 2017-2027 (USD MILLION)
TABLE 11 US: MICROFLUIDICS DEVICES MARKET, BY MATERIAL, 2017-2027 (USD MILLION)
TABLE 12 US: MICROFLUIDICS DEVICES MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 13 CANADA: MICROFLUIDICS DEVICES MARKET, BY INDUSTRY, 2017-2027 (USD MILLION)
TABLE 14 CANADA: MICROFLUIDICS DEVICES MARKET, BY MATERIAL, 2017-2027 (USD MILLION)
TABLE 15 CANADA: MICROFLUIDICS DEVICES MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 16 SOUTH AMERICA: MICROFLUIDICS DEVICES MARKET, BY INDUSTRY, 2017-2027 (USD MILLION)
TABLE 17 SOUTH AMERICA: MICROFLUIDICS DEVICES MARKET, BY MATERIAL, 2017-2027 (USD MILLION)
TABLE 18 SOUTH AMERICA: MICROFLUIDICS DEVICES MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 19 EUROPE: MICROFLUIDICS DEVICES MARKET, BY INDUSTRY, 2017-2027 (USD MILLION)
TABLE 20 EUROPE: MICROFLUIDICS DEVICES MARKET, BY MATERIAL, 2017-2027 (USD MILLION)
TABLE 21 EUROPE: MICROFLUIDICS DEVICES MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 22 WESTERN EUROPE: MICROFLUIDICS DEVICES MARKET, BY INDUSTRY, 2017-2027 (USD MILLION)
TABLE 23 WESTERN EUROPE: MICROFLUIDICS DEVICES MARKET, BY MATERIAL, 2017-2027 (USD MILLION)
TABLE 24 WESTERN EUROPE: MICROFLUIDICS DEVICES MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 25 EASTERN EUROPE: MICROFLUIDICS DEVICES MARKET, BY INDUSTRY, 2017-2027 (USD MILLION)
TABLE 26 EASTERN EUROPE: MICROFLUIDICS DEVICES MARKET, BY MATERIAL, 2017-2027 (USD MILLION)
TABLE 27 EASTERN EUROPE: MICROFLUIDICS DEVICES MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 28 ASIA-PACIFIC: MICROFLUIDICS DEVICES MARKET, BY INDUSTRY, 2017-2027 (USD MILLION)
TABLE 29 ASIA-PACIFIC: MICROFLUIDICS DEVICES MARKET, BY MATERIAL, 2017-2027 (USD MILLION)
TABLE 30 ASIA-PACIFIC: MICROFLUIDICS DEVICES MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA: MICROFLUIDICS DEVICES MARKET, BY INDUSTRY, 2017-2027 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA: MICROFLUIDICS DEVICES MARKET, BY MATERIAL, 2017-2027 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA: MICROFLUIDICS DEVICES MARKET, BY APPLICATION, 2017-2027 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS
FIGURE 2 SEGMENTATION FOR GLOBAL MICROFLUIDICS DEVICES MARKET
FIGURE 3 MARKET DYNAMICS FOR GLOBAL MICROFLUIDICS DEVICES MARKET
FIGURE 4 MICROFLUIDICS DEVICES MARKET SHARE, BY INDUSTRY, 2017
FIGURE 5 MICROFLUIDICS DEVICES MARKET SHARE, BY MATERIAL, 2017
FIGURE 6 MICROFLUIDICS DEVICES MARKET SHARE, BY APPLICATION, 2017
FIGURE 7 MICROFLUIDICS DEVICES MARKET SHARE, BY REGION, 2017
FIGURE 8 NORTH AMERICA: MICROFLUIDICS DEVICES MARKET SHARE, BY COUNTRY, 2017
FIGURE 9 EUROPE: MICROFLUIDICS DEVICES MARKET SHARE, BY COUNTRY, 2017
FIGURE 10 ASIA-PACIFIC: MICROFLUIDICS DEVICES MARKET SHARE, BY COUNTRY, 2017
FIGURE 11 MIDDLE EAST & AFRICA: MICROFLUIDICS DEVICES MARKET SHARE, BY REGION, 2017
FIGURE 12 MICROFLUIDICS DEVICES MARKET: COMPANY SHARE ANALYSIS, 2017 (%)
FIGURE 12 ABBOTT LABORATORIES: KEY FINANCIALS
FIGURE 13 ABBOTT LABORATORIES: SEGMENTAL REVENUE
FIGURE 14 ABBOTT LABORATORIES: GEOGRAPHICAL REVENUE
FIGURE 15 F. HOFFMANN-LA ROCHE AG: KEY FINANCIALS
FIGURE 16 F. HOFFMANN-LA ROCHE AG: SEGMENTAL REVENUE
FIGURE 17 F. HOFFMANN-LA ROCHE AG: GEOGRAPHICAL REVENUE
FIGURE 18 AGILENT TECHNOLOGIES, INC.: KEY FINANCIALS
FIGURE 19 AGILENT TECHNOLOGIES, INC.: SEGMENTAL REVENUE
FIGURE 20 AGILENT TECHNOLOGIES, INC.: GEOGRAPHICAL REVENUE
FIGURE 21 SIEMENS: KEY FINANCIALS
FIGURE 22 SIEMENS: SEGMENTAL REVENUE
FIGURE 23 SIEMENS: GEOGRAPHICAL REVENUE
FIGURE 24 FLUIDIGM: KEY FINANCIALS
FIGURE 25 FLUIDIGM: SEGMENTAL REVENUE
FIGURE 26 FLUIDIGM: GEOGRAPHICAL REVENUE
FIGURE 27 BIO-RAD LABORATORIES, INC.: KEY FINANCIALS
FIGURE 28 BIO-RAD LABORATORIES, INC.: SEGMENTAL REVENUE
FIGURE 29 BIO-RAD LABORATORIES, INC.: GEOGRAPHICAL REVENUE
FIGURE 30 RAINDANCE TECHNOLOGIES, INC.: KEY FINANCIALS
FIGURE 31 RAINDANCE TECHNOLOGIES, INC.: SEGMENTAL REVENUE
FIGURE 32 RAINDANCE TECHNOLOGIES, INC.: GEOGRAPHICAL REVENUE
FIGURE 33 DOLOMITE MICROFLUIDICS: KEY FINANCIALS
FIGURE 34 DOLOMITE MICROFLUIDICS: SEGMENTAL REVENUE
FIGURE 35 DOLOMITE MICROFLUIDICS: GEOGRAPHICAL REVENUE
FIGURE 36 MICRONIT MICROTECHNOLOGIES: KEY FINANCIALS
FIGURE 37 MICRONIT MICROTECHNOLOGIES: SEGMENTAL REVENUE
FIGURE 38 MICRONIT MICROTECHNOLOGIES: GEOGRAPHICAL REVENUE
FIGURE 39 CEPHEID: KEY FINANCIALS
FIGURE 40 CEPHEID: SEGMENTAL REVENUE
FIGURE 41 CEPHEID: GEOGRAPHICAL REVENUE
FIGURE 42 BD: KEY FINANCIALS
FIGURE 43 BD: SEGMENTAL REVENUE
FIGURE 44 BD: GEOGRAPHICAL REVENUE
FIGURE 45 ELVEFLOW: KEY FINANCIALS
FIGURE 46 ELVEFLOW: SEGMENTAL REVENUE
FIGURE 47 ELVEFLOW: GEOGRAPHICAL REVENUE
FIGURE 48 PERKINELMER INC.: KEY FINANCIALS
FIGURE 49 PERKINELMER INC.: SEGMENTAL REVENUE
FIGURE 50 PERKINELMER INC.: GEOGRAPHICAL REVENUE
FIGURE 51 THERMO FISHER SCIENTIFIC INC.: KEY FINANCIALS
FIGURE 52 THERMO FISHER SCIENTIFIC INC.: SEGMENTAL REVENUE
FIGURE 53 THERMO FISHER SCIENTIFIC INC.: GEOGRAPHICAL REVENUE
FIGURE 54 BIOMERIEUX: KEY FINANCIALS
FIGURE 55 BIOMERIEUX: SEGMENTAL REVENUE
FIGURE 56 BIOMERIEUX: GEOGRAPHICAL REVENUE

Product Code: MRFR/MED/0213-CR

Market Overview

The Microfluidic Device is an innovative technology that combines several medical tests on a single chip, enabling integration, industrialization, miniaturization, and parallelization of various tests in different fields of drug development, biological research, and diagnosis. The growth of the Microfluidic Devices market is primarily driven by the increasing demand for microfluidic technologies to miniaturize the chip and testing products, as well as the rising demand for genomics and proteomics. Another significant advantage of microfluidics devices is their ability to analyze small volumes of samples, resulting in less reagent waste and preservation of samples that are difficult to produce.

The demand for low-volume sample devices has surged with the introduction of microfluidics devices, and the research activities undertaken by analytical and clinical researchers have also contributed to the demand for microfluidics devices. Conventional genome analysis methods require the decoding of the entire DNA, leading to increased analysis costs and time. In contrast, microfluidics devices require only a small volume of samples for data interpretation, and the application of microfluidics has enabled conventional laboratory procedures to be miniaturized onto a lab-on-a-chip.

Segment Overview

The Microfluidic Devices market is categorized into different segments based on industry, materials, application, and regions. During the forecast period, the market is predicted to experience significant growth. In terms of application, the market is divided into various categories, including clinical and veterinary diagnostics, pharmaceutical and life science research, environmental, care diagnostics, point of analytical devices, drug delivery and industrial, and others. Additionally, based on propulsion types, the market is segmented into medical devices, in-veto diagnostics, pharmaceutical, and others.

Regional Analysis

The microfluidics market in North America is the dominant region. The growth in the market is mainly attributed to the increased research funding from government organizations and industries. The demand for microfluidics devices in the research and diagnostics field has led to an increase in industry-academia collaboration, which has accelerated the commercialization of lab-built devices.

For instance, in July 2020, Fluidigm Corporation entered into a letter contract with the National Institute of Biomedical Imaging and Bioengineering and the National Institutes of Health for the Rapid Acceleration of Diagnostics program. The program had an overall proposed budget of up to USD 37 million and aimed to expand the output capabilities and production capacity for COVID-19 testing with microfluidics technology from Fluidigm. Additionally, the program fast-tracked the commercialization and development of innovative technologies to significantly increase testing capacity for SARS-CoV-2 in the U.S.

Major Players

Key players in the market are Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Micronit Microtechnologies, Johnson & Johnson Services, Inc., Abbott Laboratories, Dolomite Microfluidics, Siemens, Fluidigm, CEPHEID, F. HOFFMANN-LA ROCHE AG, RainDance Technologies, Inc., Elveflow, Perkinelmer Inc., BIO-RAD LABORATORIES, INC., and BioMerieux.

COVID 19 Impacts

The global Microfluidics Device Market has been significantly impacted by the COVID-19 pandemic, resulting in both positive and negative effects. The market experienced a surge in demand for microfluidic devices, especially diagnostic devices, due to the urgent need for rapid and accurate testing during the pandemic. The development of microfluidic-based diagnostic tools for COVID-19 testing played a vital role in managing and controlling the spread of the disease.

However, the pandemic has also had negative impacts on the microfluidics market, such as supply chain disruptions, workforce shortages, and reduced funding for research and development activities. Manufacturing facilities shutting down, as well as trade and transportation restrictions, led to product delivery delays that hindered the market's growth

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 Market Introduction

2.1 Definition
2.2 Scope Of The Study
- 2.2.1 Research Objective
- 2.2.2 Assumptions
- 2.2.3 Limitations

3 Research Methodology

3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation

4 Market Dynamics

4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Macroeconomic Indicators
4.5 Trends & Assessment

5 Market Factor Analysis

5.1 Porter's Five Forces Analysis
- 5.1.1 Bargaining Power Of Suppliers
- 5.1.2 Bargaining Power Of Buyers
- 5.1.3 Threat Of New Entrants
- 5.1.4 Threat Of Substitutes
- 5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Opportunities

6 Microfluidics Devices Market, By Industry

6.1 Introduction
6.2 In-Vitro Diagnostics

Market Estimates & Forecast, By Region, 2017-2027

Market Estimates & Forecast, By Country, 2017-2027

6.3 Pharmaceutical
- 6.3.1 Chips For Lab Analytics

Market Estimates & Forecast, By Region, 2017-2027

Market Estimates & Forecast, By Country, 2017-2027

6.3.2 Accurate Dispensing Devices

Market Estimates & Forecast, By Region, 2017-2027

Market Estimates & Forecast, By Country, 2017-2027

6.3.3 Micro-Reactors For Drug Synthesis

Market Estimates & Forecast, By Region, 2017-2027

Market Estimates & Forecast, By Country, 2017-2027

6.4 Medical Devices
- 6.4.1 Micro Pumps And Dispensing System

Market Estimates & Forecast, By Region, 2017-2027

Market Estimates & Forecast, By Country, 2017-2027

6.4.2 Inhalers

Market Estimates & Forecast, By Region, 2017-2027

Market Estimates & Forecast, By Country, 2017-2027

6.4.3 Micro-Needles

Market Estimates & Forecast, By Region, 2017-2027

Market Estimates & Forecast, By Country, 2017-2027

6.4.4 Others

Market Estimates & Forecast, By Region, 2017-2027

Market Estimates & Forecast, By Country, 2017-2027

6.5 Others

Market Estimates & Forecast, By Region, 2017-2027

Market Estimates & Forecast, By Country, 2017-2027

7 Microfluidics Devices Market, By Material

7.1 Introduction
7.2 Polymer

Market Estimates & Forecast, By Region, 2017-2027

Market Estimates & Forecast, By Country, 2017-2027

7.3 Glass

Market Estimates & Forecast, By Region, 2017-2027

Market Estimates & Forecast, By Country, 2017-2027

7.4 Silicon

Market Estimates & Forecast, By Region, 2017-2027

Market Estimates & Forecast, By Country, 2017-2027

7.5 Others

Market Estimates & Forecast, By Region, 2017-2027

Market Estimates & Forecast, By Country, 2017-2027

8 Microfluidics Devices Market, By Application

8.1 Introduction
8.2 Pharmaceutical And Life Science Research

Market Estimates & Forecast, By Region, 2017-2027

Market Estimates & Forecast, By Country, 2017-2027

8.3 Clinical And Veterinary Diagnostics

Market Estimates & Forecast, By Region, 2017-2027

Market Estimates & Forecast, By Country, 2017-2027

8.4 Point Of Care Diagnostics

Market Estimates & Forecast, By Region, 2017-2027

Market Estimates & Forecast, By Country, 2017-2027

8.5 Analytical Devices

Market Estimates & Forecast, By Region, 2017-2027

Market Estimates & Forecast, By Country, 2017-2027

8.6 Drug Delivery

Market Estimates & Forecast, By Region, 2017-2027

Market Estimates & Forecast, By Country, 2017-2027

8.7 Environmental And Industrial

Market Estimates & Forecast, By Region, 2017-2027

Market Estimates & Forecast, By Country, 2017-2027

8.8 Others

Market Estimates & Forecast, By Region, 2017-2027

Market Estimates & Forecast, By Country, 2017-2027